These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16597680)

  • 61. Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies.
    Lv W; Booz GW; Fan F; Wang Y; Roman RJ
    Front Physiol; 2018; 9():105. PubMed ID: 29503620
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Relaxin-mediated renal vasodilation in the rat is associated with falls in glomerular blood pressure.
    Deng A; Conrad K; Baylis C
    Am J Physiol Regul Integr Comp Physiol; 2018 Feb; 314(2):R147-R152. PubMed ID: 29046312
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats.
    Wang D; Luo Y; Myakala K; Orlicky DJ; Dobrinskikh E; Wang X; Levi M
    Sci Rep; 2017 Aug; 7(1):9793. PubMed ID: 28851937
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Novel Anti-fibrotic Therapies.
    McVicker BL; Bennett RG
    Front Pharmacol; 2017; 8():318. PubMed ID: 28620300
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin.
    Wetzl V; Schinner E; Kees F; Hofmann F; Faerber L; Schlossmann J
    Front Pharmacol; 2016; 7():195. PubMed ID: 27462268
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protection.
    Díez J; Ruilope LM
    Eur Heart J Cardiovasc Pharmacother; 2016 Apr; 2(2):119-30. PubMed ID: 27418970
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate.
    Wang C; Kemp-Harper BK; Kocan M; Ang SY; Hewitson TD; Samuel CS
    Front Pharmacol; 2016; 7():91. PubMed ID: 27065874
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin.
    Schmieder RE; Mitrovic V; Hengstenberg C
    Clin Res Cardiol; 2015 Aug; 104(8):621-31. PubMed ID: 25787721
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyclic nucleotide signalling in kidney fibrosis.
    Schinner E; Wetzl V; Schlossmann J
    Int J Mol Sci; 2015 Jan; 16(2):2320-51. PubMed ID: 25622251
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New targets for renal interstitial fibrosis: relaxin family peptide receptor 1-angiotensin type 2 receptor heterodimers.
    Sasser JM
    Kidney Int; 2014 Jul; 86(1):9-10. PubMed ID: 24978374
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?
    Conrad KP; Davison JM
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1121-35. PubMed ID: 24647709
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.
    Sasser JM
    Am J Physiol Regul Integr Comp Physiol; 2013 Sep; 305(6):R559-65. PubMed ID: 23883673
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of relaxin on arterial dilation, remodeling, and mechanical properties.
    Conrad KP; Shroff SG
    Curr Hypertens Rep; 2011 Dec; 13(6):409-20. PubMed ID: 21971830
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relaxin ameliorates hypertension and increases nitric oxide metabolite excretion in angiotensin II but not N(ω)-nitro-L-arginine methyl ester hypertensive rats.
    Sasser JM; Molnar M; Baylis C
    Hypertension; 2011 Aug; 58(2):197-204. PubMed ID: 21670419
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Maternal vasodilation in pregnancy: the emerging role of relaxin.
    Conrad KP
    Am J Physiol Regul Integr Comp Physiol; 2011 Aug; 301(2):R267-75. PubMed ID: 21613576
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia.
    Conrad KP
    Semin Nephrol; 2011 Jan; 31(1):15-32. PubMed ID: 21266262
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Unveiling the vasodilatory actions and mechanisms of relaxin.
    Conrad KP
    Hypertension; 2010 Jul; 56(1):2-9. PubMed ID: 20497994
    [No Abstract]   [Full Text] [Related]  

  • 78. Relaxin: review of biology and potential role in treating heart failure.
    Teichman SL; Unemori E; Teerlink JR; Cotter G; Metra M
    Curr Heart Fail Rep; 2010 Jun; 7(2):75-82. PubMed ID: 20424993
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relaxin and its role in the development and treatment of fibrosis.
    Bennett RG
    Transl Res; 2009 Jul; 154(1):1-6. PubMed ID: 19524867
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relaxin improves renal function and histology in aging Munich Wistar rats.
    Danielson LA; Welford A; Harris A
    J Am Soc Nephrol; 2006 May; 17(5):1325-33. PubMed ID: 16597680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.